Integration of investigational drug services in an oncology service line.

The article discusses an integrated investigational drug service (IDS) model for the preparation of inpatient, outpatient, investigational and commercial oncology doses. It mentions the importance of an integrated IDS model within an oncology service line to ensure the dispensation of the correct therapies at the correct time, factors considered for model implementation including content experts, access to protocol information and standard practices, and the operational structure of the model.